Evidence map›Paper›PMID 26677256›Full record

ArticleJournal of clinical microbiology2016

Clinical and Molecular Characterization of Invasive Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Infections in Korean Hospitals.

Eu Suk Kim, In-Gyu Bae, Jeong Eun Cho, Yun Jung Choi, Il-Hwan Kim, Gi-Su Kang, Hye-yun Sin, Kyoung-Ho Song, Chulmin Park, Dong-Gun Lee and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. agr functionality affects clinical outcomes in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Eu Suk KimDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
In-Gyu BaeDepartment of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea.
Jeong Eun ChoDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
Yun Jung ChoiDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
Il-Hwan KimDivision of Antimicrobial Resistance, Center for Infectious Diseases, Korea National Institute of Health, KCDC, Cheongju, South Korea.
Gi-Su KangDivision of Antimicrobial Resistance, Center for Infectious Diseases, Korea National Institute of Health, KCDC, Cheongju, South Korea.
Hye-yun SinDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
Kyoung-Ho SongDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Chulmin ParkVaccine Bio Research Institute, The Catholic University of Korea, Seoul, South Korea.
Dong-Gun LeeVaccine Bio Research Institute, The Catholic University of Korea, Seoul, South Korea Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea.ORCID http://orcid.org/0000-0003-4655-0641
Moonsuk KimDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Kyoung Un ParkDepartment of Laboratory Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Hong Bin KimDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea hbkimmd@snu.ac.kr.ORCID http://orcid.org/0000-0001-6262-372X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive heteroresistant vancomycin-intermediate Staphylococcus aureus (h-VISA) isolates were identified and characterized in 10 Korean hospitals from July 2009 to June 2011. The prevalence of h-VISA infections was 3.3% (42/1,289). Most (41/42) were health care-associated infections caused by strains belonging to sequence type 5. Cases of persistent bacteremia were frequent (17/42), and 30-day mortality was high (16/40).

Indexed as

Cross InfectionHospitalsVancomycin ResistanceAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedRepublic of KoreaStaphylococcal InfectionsStaphylococcus aureusAnti-Bacterial Agents

Identifiers

PMID26677256
PMCPMC4767959

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.